TWO:4127

Tien Liang BioTech Co., Ltd. · TWO · Healthcare · TWD · FY for 2025

Figures on this page computed 2026-11-08 13:08 UTC

Last close

n/aTWD

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
TWD
- computed
- Computed from the filing for 2025
-1.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-2.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
2.8%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
1.26Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
TWD
- computed

Safety is the furthest below its sector's middle: 0.23 against 0.58 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.08x

-2.67x

0.76x

2.42x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales1.08x
Its own average over 7 years, 474.8M.
Profit-2.67x
Its own average over 7 years, 3.8M.
Free cash flow0.76x
Its own average over 7 years, 18.9M.
Debt2.42x
Its own average over 6 years, 247.3M.
Pricen/a
Its own average over 0 years. Market data

Profit is furthest from its own average, at -2.67 times.

Sales is 1.08 times its own 7-year average; Profit is -2.67 times its own 7-year average; Free cash flow is 0.76 times its own 7-year average; Debt is 2.42 times its own 6-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales against its own 7-year average1.08
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Profit against its own 7-year average-2.67
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Free cash flow against its own 7-year average0.76
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Debt against its own 6-year average2.42
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
TWD